MetaCap

Biodesix (BDSX) vs BioNexus Gene Lab (BGLC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Biodesix is the larger company by market cap ($83.8 million vs $2.0 million), about 42.0 times the size. Biodesix converts more of its revenue into profit, with a net margin of -39.8% versus -40.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDSX-71.39%BGLC-49.25%
+7%-34%-75%
Oct 7, 20261 yearNov 20, 2026
BDSX-70.95%BGLC-47.29%
+4%-35%-74%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDSX versus BGLC key metrics
MetricBDSXBGLC
Share price$7.56$0.68
Market cap$83.83M$1.99M
1-day change-8.92%0.00%
YTD return+11.18%—
1-year return+10.69%—
5-year return-94.38%—
EPS (TTM)$-2.69$-1.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$88.50M$7.42M
Revenue growth (YoY)+24.08%-21.93%
Net income (latest FY)$-35.27M$-2.98M
Gross margin—14.62%
Operating margin-31.50%-39.93%
Net margin-39.85%-40.20%
52-week high$31.97$4.97
52-week low$5.26$0.621
Distance from 52-week high-76.35%-86.32%
Analyst consensusstrong_buy—
Avg. price target upside+347.49%—
Average volume164.58K6.70K
Shares outstanding11.09M2.93M
Employees33419
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Biodesix is about 42.0 times larger than BioNexus Gene Lab by market value ($83.83M vs $1.99M).
  • Biodesix grew revenue faster in its latest fiscal year (+24.08% vs -21.93%).

About Biodesix

BDSX stock →

Biodesix, Inc. operates as a diagnostic solutions company.

Health Care · Medical Specialities · 334 employees

About BioNexus Gene Lab

BGLC stock →

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.

Health Care · Medical Specialities · 19 employees

BDSX vs BGLC FAQ

Which is bigger, Biodesix or BioNexus Gene Lab?

Biodesix (BDSX) is larger, with a market capitalization of $83.83M compared with $1.99M for BioNexus Gene Lab (BGLC).

Are Biodesix and BioNexus Gene Lab in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons